Ik-Joo Chung

5PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 16, 2024
Tumor Immune Microenvironment Biomarkers for Recurrence Prediction in Locally Advanced Rectal Cancer Patients after Neoadjuvant Chemoradiotherapy.

Jun-Eul Hwang, Sung-Sun Kim, Hyun-Jin Bang

|Jul 29, 2024
Galectin 3-binding protein (LGALS3BP) depletion attenuates hepatic fibrosis by reducing transforming growth factor-β1 (TGF-β1) availability and inhibits hepatocarcinogenesis.

Dae-Hwan Kim, Minjeong Sung, Myong-Suk Park

|Jul 12, 2024
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY.

Yoon-Koo Kang, Hyung-Don Kim, Jeong Hwan Yook

|Apr 11, 2023
Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-α-TAK1-MMP9 axis.

Eun-Gene Sun, Veena Vijayan, Mi-Ra Park

|Jun 16, 2021
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.

Yoon-Koo Kang, Jeong Hwan Yook, Young-Kyu Park

Pageof 1

Frequent Collaborators

2 joint publications

Yoon-Koo Kang

2 joint publications

Sun Young Rha

2 joint publications

Sung Hoon Noh

2 joint publications

Baek-Yeol Ryoo